FDA warns Curaleaf about inflated claims in CBD marketing

FDA warns Curaleaf about inflated claims in CBD marketing The Food & Drug Administration has issued a warning to Curaleaf for marketing its CBD products with “unsubstantiated” health claims. Recently, this …

বাংলা简体中文繁體中文EnglishFrançaisDeutschहिन्दीItaliano日本語한국어मराठीPortuguêsਪੰਜਾਬੀРусскийEspañolSvenskaతెలుగుไทยTürkçeУкраїнськаTiếng Việt